299.2500 -7.00 (-2.29%)
NSE Mar 19, 2026 15:31 PM
Volume: 334.2K
 

299.25
-2.29%
ICICI Securities Limited
Suven’s rapid ascendance in the CDMO space has been remarkable. It has journeyed from being a small molecule-focused CDMO to achieving eminence as one of the few CDMOs in India that offers contract manufacturing of oligonucleotides and ADCs.
Number of MF schemes decreased from 30 to 24 in Dec 2025 qtr
More from Cohance Lifesciences Ltd.
Recommended